X T L Biopharmaceuticals reported 138K in Debt for its fiscal quarter ending in December of 2024.


Debt Change Date
Alaunos Therapeutics USD 0 0 Dec/2024
Bioline Rx USD 12.6M 1.14M Jun/2025
Teva Pharmaceutical Industries USD 17.52B 872M Jun/2025
X T L Biopharmaceuticals 138K 30K Dec/2024